Mediastinal (thymic) large B-cell lymphoma: where do we stand?
- 1 April 2002
- journal article
- review article
- Published by Elsevier in The Lancet Oncology
- Vol. 3 (4) , 229-234
- https://doi.org/10.1016/s1470-2045(02)00714-3
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- The outcome of combined-modality treatments for stage I and II primary large B-cell lymphoma of the mediastinumInternational Journal of Radiation Oncology*Biology*Physics, 2000
- MACOP-B and involved field radiation therapy is an effective therapy for primary mediastinal large B-cell lymphoma with sclerosisAnnals of Oncology, 1998
- A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's LymphomaBlood, 1997
- Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: a multicenter study of 106 patients.Journal of Clinical Oncology, 1997
- A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments]Blood, 1994
- Mediastinal large‐cell lymphoma of B‐type, with sclerosis: Histopathological and immunohistochemical study of eight casesHistopathology, 1986
- Large cell lymphoma of the mediastinum: a B‐cell tumour of probable thymic originHistopathology, 1986
- Primary mediastinal clear cell lymphomaVirchows Archiv, 1986
- Primary Non-Hodgkin's lymphoma of the mediastinumCancer, 1982
- Diffuse large cell and undifferentiated lymphomas with promiment mediastinal involvement. A poor prognoctic subset of patients with non-Hodgkin's lymphomaCancer, 1982